Veritable’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,796
Closed -$1.46M 342
2023
Q2
$1.46M Sell
4,796
-126
-3% -$38.2K 0.02% 294
2023
Q1
$1.3M Buy
4,922
+282
+6% +$74.4K 0.02% 309
2022
Q4
$1.11M Buy
4,640
+134
+3% +$32.2K 0.02% 332
2022
Q3
$828K Buy
4,506
+223
+5% +$41K 0.02% 389
2022
Q2
$720K Buy
4,283
+390
+10% +$65.6K 0.01% 451
2022
Q1
$976K Buy
3,893
+92
+2% +$23.1K 0.02% 406
2021
Q4
$977K Buy
3,801
+96
+3% +$24.7K 0.01% 404
2021
Q3
$899K Buy
3,705
+29
+0.8% +$7.04K 0.01% 405
2021
Q2
$760K Buy
3,676
+106
+3% +$21.9K 0.01% 438
2021
Q1
$672K Buy
3,570
+22
+0.6% +$4.14K 0.01% 446
2020
Q4
$584K Sell
3,548
-1,008
-22% -$166K 0.01% 455
2020
Q3
$568K Sell
4,556
-139
-3% -$17.3K 0.01% 436
2020
Q2
$456K Sell
4,695
-286
-6% -$27.8K 0.01% 488
2020
Q1
$448K Sell
4,981
-261
-5% -$23.5K 0.01% 470
2019
Q4
$775K Buy
5,242
+191
+4% +$28.2K 0.01% 418
2019
Q3
$608K Buy
5,051
+10
+0.2% +$1.2K 0.01% 462
2019
Q2
$681K Buy
5,041
+68
+1% +$9.19K 0.01% 427
2019
Q1
$648K Sell
4,973
-38
-0.8% -$4.95K 0.01% 437
2018
Q4
$624K Sell
5,011
-488
-9% -$60.8K 0.01% 409
2018
Q3
$765K Sell
5,499
-3,515
-39% -$489K 0.02% 397
2018
Q2
$925K Buy
9,014
+383
+4% +$39.3K 0.02% 352
2018
Q1
$837K Sell
8,631
-2,634
-23% -$255K 0.02% 370
2017
Q4
$990K Sell
11,265
-1,816
-14% -$160K 0.02% 331
2017
Q3
$1.04M Buy
13,081
+744
+6% +$59.2K 0.02% 334
2017
Q2
$1.08M Buy
12,337
+958
+8% +$83.6K 0.02% 336
2017
Q1
$1.01M Buy
11,379
+894
+9% +$79.6K 0.02% 328
2016
Q4
$776K Buy
10,485
+1,961
+23% +$145K 0.02% 359
2016
Q3
$645K Buy
8,524
+486
+6% +$36.8K 0.02% 407
2016
Q2
$619K Buy
8,038
+1,933
+32% +$149K 0.02% 394
2016
Q1
$476K Buy
6,105
+3,083
+102% +$240K 0.01% 452
2015
Q4
$204K Sell
3,022
-1,596
-35% -$108K 0.01% 680
2015
Q3
$357K Buy
4,618
+356
+8% +$27.5K 0.01% 527
2015
Q2
$387K Sell
4,262
-2,955
-41% -$268K 0.01% 527
2015
Q1
$543K Sell
7,217
-153
-2% -$11.5K 0.01% 579
2014
Q4
$541K Buy
7,370
+2,102
+40% +$154K 0.01% 581
2014
Q3
$371K Buy
+5,268
New +$371K 0.01% 700